Search

file (14) (1)

Investor Overview

Investor Overview

HOMEInvestor Overview

Read More

2025.Feb.20

News

OBI Pharma Showcases Proprietary ADC Platform GlycOBI® in China
Drawing Strong Industry Interest

2025.Feb.19

News

Invited to the 2025 Healthcare Conference in Taipei
Dr. Heidi Wang engaged in discussions on Regulatory Landscape and International Partnerships in Pharma and Diagnostics

2024.Dec.31

News

OBI Pharma's OBI-992 Research Paper Featured on Cover and Selected as a First Disclosure Article in Molecular Cancer Therapeutics Journal

Read More

2025.Feb.18

Announcement

Announcement on behalf of OBIGEN Pharma the new appointment of CEO

2025.Feb.18

Announcement

Announcement on behalf of OBIGEN Pharma of the BOD’s resolution to lift the non-competition restrictions for CEO

2025.Jan.22

Announcement

Announcement on behalf of OBIGEN that TFDA clears OBI-858’s IND application for repeat-dose Phase II safety study

2023 Annual Report

Learn how we created value in 2023 and worked to pursue our purpose of enabling a healthier world.

Download PDF
Read More

Featured
Presentation

2024 Investors' Meeting - Innovation and Optimism

Download PDFAnnual Report

Read More

2024 Annual Shareholders’ Meeting

  • 2024.Jun.17 at 09:00 AM
  • Masterlink Securities Education and Training Center

Governance

Read More

Corporate
Overview​

Board of
Directors​

Special ​
Committee​

Integrity​

Internal
Audit​

Governance
Document​

Investor Relations

Contact